These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 406437)

  • 21. The toxic antigenic factors produced by Clostridium botulinum types C and D.
    Jansen BC
    Onderstepoort J Vet Res; 1971 Jun; 38(2):93-8. PubMed ID: 4950122
    [No Abstract]   [Full Text] [Related]  

  • 22. Proceedings: Bacteriophages and toxigenicity in Clostridium botulinum types C and D.
    Oguma K; Iida H; Inoue K
    Jpn J Med Sci Biol; 1975 Feb; 28(1):63-6. PubMed ID: 1099282
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of prednisolone, periston-N and antitoxic serum on the absorption and localization of I-131-labelled Clostridium botulinum B toxin in guinea pigs].
    Stempień R; Fabianowski J; Ubysz-Jerzmanowska K; Brühl A
    Pol Tyg Lek; 1967 May; 22(18):665-8. PubMed ID: 4865249
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of potency tests of a vaccine against Cl. botulinum type C by different methods.
    Pranter W
    Dev Biol Stand; 1976; 32():185-91. PubMed ID: 793914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological heterogeneity of Clostridium botulinum type B toxins.
    Shimizu T; Kondo H; Sakaguchi G
    Jpn J Med Sci Biol; 1974 Apr; 27(2):99-100. PubMed ID: 4134872
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on strain 84 of Clostridium botulinum.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig; 1970; 215(2):212-20. PubMed ID: 4992024
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Jpn J Med Sci Biol; 1975; 28(5-6):301-4. PubMed ID: 778448
    [No Abstract]   [Full Text] [Related]  

  • 29. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophoretic analysis of Clostridium botulinum types A and B hemagglutinins.
    DasGupta BR
    Can J Microbiol; 1980 Aug; 26(8):992-7. PubMed ID: 7006771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenicity of converting phages obtained from Clostridium botulinum types C and D.
    Oguma K; Iida H; Shiozaki M; Inoue K
    Infect Immun; 1976 Mar; 13(3):855-60. PubMed ID: 773828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
    Kouguchi H; Suzuki T; Hasegawa K; Mutoh S; Watanabe T; Niwa K; Yoneyama T; Katoh Y; Ohyama T
    J Microbiol Methods; 2006 Dec; 67(3):416-23. PubMed ID: 16725219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.
    Wu HC; Yeh CT; Huang YL; Tarn LJ; Lung CC
    Appl Environ Microbiol; 2001 Jul; 67(7):3201-7. PubMed ID: 11425742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemagglutinin from Rotavirus.
    Spence L; Fauvel M; Petro R; Bloch S
    Lancet; 1976 Nov; 2(7993):1023. PubMed ID: 62238
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H
    Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():31-44. PubMed ID: 800280
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on the effect of the diluent used for diluting challenge toxin in the Clostridium botulinum potency test.
    Sawtell JA; Ream AJ
    Biologicals; 1995 Sep; 23(3):249-51. PubMed ID: 8527126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serological examinations with apathogenic clostridia (M 55) (author's transl)].
    Gericke D; Vèrtesy L
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):303-7. PubMed ID: 1237207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes.
    Suzuki JB; Booth RR; Grecz N
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):691-711. PubMed ID: 4944551
    [No Abstract]   [Full Text] [Related]  

  • 39. [Investigations on the capacity of di-toxin and -toxoid to combine with hemagglutinin of the guinea pig, rabbit, sheep, horse and man].
    SEEMULLER H
    Schweiz Z Pathol Bakteriol; 1950; 13(5):635-41. PubMed ID: 14828353
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological properties of Hn-33 purified from type A Clostridium botulinum.
    Sharma SK; Singh BR
    J Nat Toxins; 2000 Nov; 9(4):357-62. PubMed ID: 11126514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.